Data Bridge Market Research has added a new market report on “Global Internal Neuromodulation Devices Market – Analysis and Forecast 2013 – 2020” to their product portfolio of healthcare reports.

Global Internal Neuromodulation Devices Market By Product (Spinal Cord Stimulator, Deep Brain Stimulator, Vagus Nerve Stimulator, Sacral Nerve Stimulator, Gastric Nerve Stimulator), By Indication (Failed Back Surgery Syndrome, Parkinson’s disease, Urinary Incontinence, Epilepsy, Gastroparesis), By Battery Type (Primary, Rechargeable), By Geography (North America, Europe, Asia-Pacific, Rest of the World)

 The Global Internal Neuromodulation devices market is driven by the rising incidence of failed back surgeries, Parkinson’s disease, urinary incontinence and other related indications. Also the market is experiencing a rising surge of technological advancements such as the new internal neuromodulation device from Enteromedics for the treatment of obesity related disorders. The market is in its lag phase very soon expected to enter the growth phase, due to major influx of market players in the recent years.

The report also covers a complete competitive landscape including the company shares, recent developments, mergers and acquisitions, new product launches and company profiles with product and revenue matrix. Some of the major players operating in this market are Medtronic, Boston Scientific Corporation, St. Jude Medical, Inc., Nexro Corporation, Cyberonics, Inc. among other companies.

 For free sample of the report

Mail at

sales@databridgemarketresearch.com

Or visit

http://databridgemarketresearch.com/reports/global-internal-neuromodulation-devices-market/